Finance

Lists
Why is BHC up 2,58%?
Dive Deeper
BHC:NYSE
Bausch Health Companies Inc
8,34 US$
+2,58%
(+0,21) 1D
8,39 US$
+0,60% (+0,050)
After hours
Closed: 4 ნოე, 16:00:02 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BHC...
Open
8,28 US$
High
8,46 US$
Low
8,22 US$
Mkt. cap
3,12 მლრდ.
Avg. vol.
3,51 მლნ.
Volume
3,53 მლნ.
52-wk high
9,04 US$
52-wk low
4,33 US$
EPS
-2,29 US$
Beta
0,30
Shares outstanding
374,27 მლნ.
No. of employees
20 ათ.
Open
8,28 US$
High
8,46 US$
Low
8,22 US$
Mkt. cap
3,12 მლრდ.
Avg. vol.
3,51 მლნ.
Volume
3,53 მლნ.
52-wk high
9,04 US$
52-wk low
4,33 US$
EPS
-2,29 US$
Beta
0,30
Shares outstanding
374,27 მლნ.
No. of employees
20 ათ.
News stories
From web sources and news partners
Yahoo! Finance Canada
Yahoo! Finance Canada
·
9 საათის წინ
BHC Q3 Earnings Call Highlights Raised Outlook, Xifaxan Risks
The Motley Fool Canada
The Motley Fool Canada
·
22 საათის წინ
What in the World Happened With Bausch Health Stock Last Week?
Profile
Bausch Health Companies Inc. is a pharmaceutical company headquartered in Laval, Quebec, Canada, with office in Bridgewater, New Jersey. It develops, manufactures and markets a range of pharmaceutical products in gastroenterology, hepatology, neuroscience, dermatology, dentistry, medical aesthetics, and international pharmaceuticals. Bausch Health manufactures and markets branded pharmaceuticals, generic pharmaceuticals, and over-the-counter products directly or indirectly in more than 90 countries and regions, including the United States, Canada, Europe, the Middle East, Africa, Asia Pacific and Latin America. Wikipedia
About Bausch Health Companies Inc
CEOთომას ჯეი აპიო
Employees20,3 ათ.
Founded1960
Headquartersლავალი, კვებეკი, კანადა
SectorPharmaceutical industry
Industry-
Analyst ratings
Based on 3 analysts giving stock ratings to BHC in the past 3 months
Hold
Buy
0
Hold
3
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for BHC in the last 3 months.
Highest
Current 8,34 US$
10,00 US$ (+19,90%)
Average
8,33 US$ (-0,12%)
Lowest
7,00 US$ (-16,07%)
Analyst
Recommendation
Action
Price target
Projected
Date
Young Li
Jefferies
Hold
Reiterated
8,00 US$
-4,1%
10/29/2026
Douglas Miehm
RBC Capital
Hold
Reiterated
10,00 US$
+19,9%
10/29/2026
Glen Santangelo
Barclays
Hold
Maintained
7,00 US$
-16,1%
10/29/2026
Les Sulewski
Truist Financial
Hold
Reiterated
-
-
05/01/2026
Michael Nedelcovych
TD Cowen
Hold
Maintained
7,00 US$
-16,1%
04/30/2026
Umer Raffat
Evercore ISI
Hold
Maintained
-
-
04/30/2026
Jason Gerberry
Bank of America Securities
Sell
Reiterated
5,00 US$
-40%
02/18/2026
Last report
28 ოქტ. 2026
Fiscal period
Q3 2026
1,77 US$ / 1,24 US$
+42,45%beat
Revenue / Est. (USD)
2,94 მლრდ. / 2,75 მლრდ.
+6,76%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
დეკ. 2025
მარ. 2026
ივნ. 2026
სექ. 2026
Revenue
2,80 მლრდ.
2,52 მლრდ.
2,85 მლრდ.
2,94 მლრდ.
Cost of goods sold
798,00 მლნ.
738,00 მლნ.
772,00 მლნ.
735,00 მლნ.
Cost of revenue
798,00 მლნ.
738,00 მლნ.
772,00 მლნ.
735,00 მლნ.
Research and development expenses
161,00 მლნ.
163,00 მლნ.
173,00 მლნ.
141,00 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
880,00 მლნ.
860,00 მლნ.
907,00 მლნ.
834,00 მლნ.
Operating expense
1,28 მლრდ.
1,26 მლრდ.
1,30 მლრდ.
1,20 მლრდ.
Total operating expenses
2,08 მლრდ.
2,00 მლრდ.
2,08 მლრდ.
1,94 მლრდ.
Operating income
721,00 მლნ.
521,00 მლნ.
775,00 მლნ.
1,01 მლრდ.
Other non operating income
-
-
-
-
EBT including unusual items
56,00 მლნ.
-1,35 მლრდ.
348,00 მლნ.
597,00 მლნ.
EBT excluding unusual items
322,00 მლნ.
118,00 მლნ.
383,00 მლნ.
620,00 მლნ.
Income tax expense
159,00 მლნ.
77,00 მლნ.
88,00 მლნ.
151,00 მლნ.
Effective tax rate
283,93%
-5,69%
25,29%
25,29%
Other operating expenses
-
1,00 მლნ.
-
-2,00 მლნ.
Net income
-112,00 მლნ.
-1,42 მლრდ.
258,00 მლნ.
436,00 მლნ.
Net profit margin
-4,01%
-56,38%
9,05%
14,82%
Earnings per share
1,10
0,78
1,26
1,77
Interest and investment income
9,00 მლნ.
10,00 მლნ.
11,00 მლნ.
13,00 მლნ.
Interest expense
-397,00 მლნ.
-402,00 მლნ.
-396,00 მლნ.
-398,00 მლნ.
Net interest expenses
-388,00 მლნ.
-392,00 მლნ.
-385,00 მლნ.
-385,00 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
1,01 მლრდ.
816,00 მლნ.
1,06 მლრდ.
1,29 მლრდ.
Gain or loss from assets sale
-
-3,00 მლნ.
-
-1,00 მლნ.
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google აპები